- Financial Times•9 hours ago
GlaxoSmithKline has poached its new global head of pharmaceuticals from rival AstraZeneca, marking a change of guard at Britain's biggest drugmaker as it prepares for the arrival of its new chief executive. ...
- Reuters•17 hours ago
LONDON/DAVOS, Switzerland, Jan 19 (Reuters) - G laxoSmithKline's global head of pharmaceuticals, Abbas Hussain, is to leave Britain's biggest drugmaker after being passed over for the top job and will be replaced by Luke Miels from AstraZeneca. Hussain, the brother of former England cricket captain Nasser Hussain, had been a contender to take over from Chief Executive Andrew Witty, who steps down at the end of March, but the job went to GSK's consumer health boss Emma Walmsley.
- Zacks•2 days ago
AstraZeneca (AZN) provided an update on its late-stage immuno-oncology program for first-line NSCLC.
AZN.L : Summary for ASTRAZENECA PLC ORD SHS $0.25 - Yahoo Finance
AstraZeneca PLC (AZN.L)
LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
|Bid||4,460.00 x 6100|
|Ask||4,556.00 x 13000|
|Day's Range||4,464.50 - 4,615.57|
|52 Week Range||3,680.00 - 5,505.00|
|PE Ratio (TTM)||22.93|
|Dividend & Yield||2.80 (4.97%)|
|1y Target Est||N/A|